Abstract
How do we design a high-quality evaluation system to ensure that we get value for money from health technology but with a process that does not impose excessive costs? This is the question at the heart of a recent review of the health technology assessment (HTA) process in Australia.
Original language | English |
---|---|
Pages (from-to) | 615-617 |
Number of pages | 3 |
Journal | Expert Review of Pharmacoeconomics and Outcomes Research |
Volume | 10 |
Issue number | 6 |
Publication status | Published - 2010 |